logo-loader
viewTrutrace Technologies Inc.

TruTrace Technologies CEO thanks shareholders for their support as the firm sees the fruits of its labour

The technology company's StrainSecure blockchain platform is being used in a new nationwide clinical cannabis trial and with a new customer in the logistics sector

Trutrace Technologies Inc. -
StrainSecure is an integrated blockchain platform that registers and tracks cannabis intellectual property from genome to sale

TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) CEO Robert Galarza thanked shareholders for their support on Tuesday after the company launched a new real-world implementation of its StrainSecure platform with Canada’s largest pharmacy chain Shoppers Drug Mart.

Earlier this week the University Health Network, in partnership with Medical Cannabis by Shoppers Drug Mart, began nationwide clinical trials studying the effects of cannabis use on chronic plain, sleep issues, anxiety and depression.

The trial will use TruTrace’s StrainSecure cannabis tracing and verification platform, an integrated blockchain platform that registers and tracks cannabis intellectual property from genome to sale.

READ: TruTrace Technologies strikes license deal with logistics group OrionOne, which will help it expand beyond cannabis space

The deployment represents a real-world implementation of StrainSecure within the Shoppers ecosystem with an aim to become a fundamental part of legalized medical cannabis for years to come, Galarza wrote in a letter to shareholders.

“(Over) the past two years we at TruTrace have been on a path to bring greater transparency and interoperability to the medical cannabis sector,” Galarza wrote.

“Our mission is aimed squarely at delivering innovative technology to bring visibility and collaboration to this emerging industry. They say nothing worth having comes easy and further, if there is one word that defines every member of our team it is simply...resiliency.”

In addition to the new study, Vancouver-based TruTrace recently inked a strategic partnership with OrionOne Global, opening up market opportunities for TruTrace in other key industries such as freight and logistics. 

In the letter, Galarza hailed the landmark deal and the Shoppers/UHN deployment.

“This is our moment,” the CEO wrote. “This is our chance to dig deeper, stay committed to road ahead, stay resilient and continue on a path to achieving our goals.”

Shares of TruTrace were trading 8.3% higher in Toronto at C$0.07 at the midday point Thursday.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Trutrace Technologies Inc.

Price: 0.075 CAD

CSE:TTT
Market: CSE
Market Cap: $6.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Trutrace Technologies Inc. named herein, including the promotion by the Company of Trutrace Technologies Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

TruTrace Technologies partner Shoppers Drug Mart looks to add more data to...

TruTrace Technologies (CSE: TTT-OTCQB: TTTSF) CEO Robert Galarza joined Steve Darling from Proactive Vancouver with news their partner company Shoppers Drug mart is now looking to increase available data from its online medical cannabis marketplace to try and allow doctors to access more...

4 weeks ago

2 min read